Skip to main content

Standard Biotools Inc.

LAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001162194

No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Standard Biotools Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of LAB: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1423145+6
Shares278.4M1.60M281.6M+4.82M (+1.7%)
Value$487.1M$2.80M$304.1M−$180.1M (−37.2%)

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Standard Biotools Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to LAB in Q1 2025
InstitutionSharesValue% of portfolio
Long Focus Capital Management, LLC6,700,000$7.24M0.49%
Mak Capital One LLC2,774,721$3.00M0.64%
Nuveen, LLC798,482$862.4K0.00%
EntryPoint Capital, LLC253,668$274.0K0.13%
XTX Topco Ltd158,087$170.7K0.01%
Oppenheimer & Co Inc86,600$93.5K0.00%
Mariner, LLC74,145$80.1K0.00%
Ieq Capital, LLC63,182$68.2K0.00%
Impact Partnership Wealth, LLC53,857$58.2K0.01%
Teacher Retirement System of Texas32,647$35.3K0.00%
Quadrature Capital Ltd30,310$32.9K0.00%
Jump Financial, LLC23,700$25.6K0.00%
Cerity Partners LLC22,031$23.8K0.00%
Wealth Enhancement Advisory Services, LLC20,250$21.9K0.00%
Dynamic Technology Lab Private Ltd16,761$18.0K0.00%
Pallas Capital Advisors LLC12,352$13.3K0.00%
Envestnet Asset Management Inc10,116$10.9K0.00%
Signaturefd, LLC5,170$5.58K0.00%
True Wealth Design, LLC1,096$1.18K0.00%
Lindbrook Capital, LLC904$9760.00%
N.E.W. Advisory Services LLC530$5720.00%
Parkside Financial Bank & Trust200$2160.00%

Sold out (16)

Institutions that held Standard Biotools Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (3)

Institutions that held Standard Biotools Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LAB in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Price Jennifer C.803,282$1.41M
Nuveen Asset Management, LLC798,482$1.40M
Global Retirement Partners, LLC880$1.54K